Xin-yi-san contains potent human CYP1A2 inhibitors and its combined use with theophylline in treatment increases adverse risks in patients

CYP1A2 茶碱 不利影响 药理学 化学 传统医学 医学 内科学 细胞色素P450 新陈代谢
作者
Li‐Ting Kao,An-Chi Chen,Hong-Jaan Wang,Yuan-Liang Wen,Chung‐Kuang Lu,Chia‐Ching Liaw,Keng‐Chang Tsai,Yune‐Fang Ueng
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:130: 155760-155760 被引量:6
标识
DOI:10.1016/j.phymed.2024.155760
摘要

The Xin-yi-san herbal decoction (XYS) is commonly used to treat patients with allergic rhinitis in Taiwan. Theophylline is primarily oxidized with high affinity by human cytochrome P450 (CYP)1A2, and has a narrow therapeutic index. This study aimed to investigate the inhibition of human CYP1A2-catalyzed theophylline oxidation (THO) by XYS and its adverse effects in patients. Human CYPs were studied in recombinant enzyme systems. The influence of concurrent XYS usage in theophylline-treated patients was retrospectively analyzed. Among the major human hepatic and respiratory CYPs, XYS inhibitors preferentially inhibited CYP1A2 activity, which determined the elimination and side effects of theophylline. Among the herbal components of XYS decoction, Angelicae Dahuricae Radix contained potent THO inhibitors. Furanocoumarin imperatorin was abundant in XYS and Angelicae Dahuricae Radix decoctions, and non-competitively inhibited THO activity with Ki values of 77‒84 nM, higher than those (20‒52 nM) of fluvoxamine, which clinically interacted with theophylline. Compared with imperatorin, the intestinal bacterial metabolite xanthotoxol caused weaker THO inhibition. Consistent with the potency of the inhibitory effects, the docking analysis generated Gold fitness values in the order−fluvoxamine > imperatorin > xanthotoxol. During 2017‒2018, 2.6% of 201,093 theophylline users consumed XYS. After inverse probability weighting, XYS users had a higher occurrence of undesired effects than non-XYS users; in particular, there was an approximately two-fold higher occurrence of headaches (odds ratio (OR), 2.14; 95% confidence interval (CI), 1.99‒2.30; p < 0.001) and tachycardia (OR, 1.83; 95% CI, 1.21‒2.77; p < 0.05). The incidence of irregular heartbeats increased (OR, 1.36; 95% CI, 1.07‒1.72; p < 0.05) only in the theophylline users who took a high cumulative dose (> 24 g) of XYS. However, the mortality in theophylline users concurrently taking XYS was lower than that in non-XYS users (OR, 0.24; 95% CI, 0.14‒0.40; p < 0.001). XYS contains human CYP1A2 inhibitors, and undesirable effects were observed in patients receiving both theophylline and XYS. Further human studies are essential to reduce mortality and to adjust the dosage of theophylline in XYS users.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
激流勇进wb完成签到 ,获得积分10
3秒前
4秒前
5秒前
天真南松完成签到,获得积分10
7秒前
YUHL完成签到 ,获得积分10
7秒前
简生pro完成签到,获得积分10
7秒前
饭特稀完成签到,获得积分10
8秒前
天天向上的应助被蟹老板采纳,获得10
8秒前
xing_xing的应助被科研通管家采纳,获得20
8秒前
Jasper的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
华仔的应助被科研通管家采纳,获得10
8秒前
9秒前
CodeCraft的应助被科研通管家采纳,获得10
9秒前
上官若男的应助被67采纳,获得10
9秒前
在水一方的应助被科研通管家采纳,获得10
9秒前
NexusExplorer的应助被科研通管家采纳,获得10
9秒前
9秒前
xing_xing的应助被科研通管家采纳,获得20
9秒前
璐璐发布了新的文献求助10
9秒前
奔跑的应助被科研通管家采纳,获得10
9秒前
我是老大的应助被科研通管家采纳,获得10
10秒前
10秒前
11秒前
12秒前
爆米花的应助被shaofeng采纳,获得10
12秒前
随缘发布了新的文献求助10
12秒前
cui完成签到 ,获得积分10
13秒前
沈恺恺发布了新的文献求助10
13秒前
小二郎的应助被大知闲闲采纳,获得10
14秒前
幽默千柔发布了新的文献求助10
14秒前
华无剑的应助被草没味采纳,获得10
15秒前
Maggie完成签到 ,获得积分10
15秒前
细心沂完成签到 ,获得积分10
15秒前
15秒前
shippou完成签到 ,获得积分10
15秒前
Yy杨优秀完成签到 ,获得积分10
17秒前
科研通AI65的应助被yqhuang采纳,获得10
17秒前
67完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186784
求助须知:如何正确求助?哪些是违规求助? 9575092
关于积分的说明 21839541
捐赠科研通 7784418
什么是DOI,文献DOI怎么找? 3434819
关于科研通互助平台的介绍 2559221
邀请新用户注册赠送积分活动 2481682